LabGenomics Co., Ltd. (KOSDAQ:084650)
1,430.00
+3.00 (0.21%)
At close: Mar 13, 2026
LabGenomics Market Cap
LabGenomics has a market cap or net worth of 106.16 billion as of March 13, 2026. Its market cap has decreased by -46.44% in one year.
Market Cap
106.16B
Enterprise Value
90.82B
Revenue
89.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,430.00
Market Cap Chart
Since December 16, 2014, LabGenomics's market cap has increased from 56.52B to 106.16B, an increase of 87.83%. That is a compound annual growth rate of 5.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 106.16B | -21.04% |
| Dec 30, 2025 | 134.45B | -27.27% |
| Dec 30, 2024 | 184.86B | -35.41% |
| Dec 28, 2023 | 286.20B | 33.64% |
| Dec 29, 2022 | 214.15B | -23.76% |
| Dec 30, 2021 | 280.90B | 31.47% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio Plus | 301.55B |
| DRTECH | 155.68B |
| T&R Biofab | 154.84B |
| Osang Healthcare Co.,Ltd | 137.51B |
| P&S Robotics | 113.20B |
| Gencurix | 91.37B |
| Ray Co., Ltd. | 82.53B |
| Sugentech | 77.21B |